Results 211 to 220 of about 58,239 (290)

JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. [PDF]

J Ophthalmic Inflamm Infect
Almerri S, Alshatti H, Ali YT, Behbehani R.   +3 more
europepmc   +1 more source

Oftalmología veterinaria II: mirada clara, limpia, transparente y cristalina [PDF]

, 2008
Cattaneo U. M.V., Dr. Gino, Flores P.M.V., Dra. E., Halabí J., María Teresa   +2 more
core   +1 more source

UVEÍTIS CRÓNICA EN LA ARTRITIS IDIOPÁTICA JUVENIL. IMPACTO PRONÓSTICO

, 2018
Maria F. Reina, Clara Malagón, María Pilar Romero‐Gómez, Angela C. Mosquera   +3 more
openalex   +1 more source

Análisis longitudinal de las complicaciones oculares en la uveítis: factores de riesgo para la pérdida de la visión y efecto de la inmunosupresión sistémica

Harold Julián Rodríguez Barreto, María Catalina Puentes Ramírez, Santiago Arias Gómez   +2 more
openalex   +1 more source

Uveítis secundaria a Borreliosis de Lyme en México [PDF]

, 2018
Alejandro Rodríguez-García, Isidora Arroyo-Garza, Beatriz E. Patiño-Ramírez   +2 more
openalex   +1 more source

Cell and Gene Therapy in Equine Ocular Disease

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young, Lauren V. Schnabel, Brian C. Gilger   +2 more
wiley   +1 more source

Bilateral acute intermediate uveitis following intrauterine Chitosan tamponade: a case series. [PDF]

J Ophthalmic Inflamm Infect
Beckers D, Pleyer U, Beckers L, Maul H, Lüder M, Schaudig U, Stemplewitz B.   +6 more
europepmc   +1 more source

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source

The prevalence and potential associations of anti-drug antibodies against adalimumab in patients with non-infectious uveitis: a cross-sectional study. [PDF]

J Ophthalmic Inflamm Infect
Madhavan A, Rogers SL, Bosco JJ, Ross L, Samalia PD, Hall AJ, Lim LL.   +6 more
europepmc   +1 more source

Parabiosis, Assembloids, Organoids (PAO)

Advanced Science, Volume 13, Issue 7, 3 February 2026.
This review evaluates parabiosis, organoids, and assembloids as complementary disease models spanning systemic, organ, and multi‐organ levels. It highlights their construction strategies, applications, and current limitations, while emphasizing their integration with frontier technologies such as artificial intelligence, organ‐on‐a‐chip, CRISPR, and ...
Yang Hong, Lavonda Li, Lijie Yan, Long Bai, Jiacan Su, Xingcai Zhang   +5 more
wiley   +1 more source